Keep REMS Requirements Straight

May 2018

Drugs with Risk Evaluation and Mitigation Strategies (REMS) are back in the spotlight...due to updates to some of these med safety programs.

The iPLEDGE program for isotretinoin will now allow pharmacies to get a Risk Management Authorization (RMA) through their pharmacy network without having to call or go to the iPLEDGE website.

Plus short-acting opioids will soon have REMS, and FDA is considering mandatory pain management training for healthcare providers.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Communication Help Patients Feel at Ease When Discussing Sensitive Topics
Inhalers Think of Qvar RediHaler as the "Breath-Actuated" Form of Qvar
Practice Find Alternatives to Meds Discontinued by the Manufacturer
Pregnancy Bonjesta Will Compete With Diclegis for Nausea and Vomiting in Pregnancy
Glaucoma Keep an Eye Out for Vyzulta and Rhopressa to Treat Glaucoma
Ophthalmology Prevent Common Eye Drop Errors
HIV & AIDS Encourage Adherence With Meds Used to Prevent HIV
Renal & Urology Look for Noctiva for Frequent Nighttime Urination in Adults
Infectious Diseases Watch for Rxs for Acute Infections in Patients on Chronic Antibiotics
Appropriate Med Use Help Patients Get Off Unneeded Meds
Med Safety Keep REMS Requirements Straight

Keep REMS Requirements Straight

Practical advice for a better career, with unlimited access to CE

Table of Contents